Versions - Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies.

    Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies. by Martin K H Ho, Araniy Santhireswaran, Tara Gomes, Muhammad Mamdani, Mina Tadrous

    Published 2025-01-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies

    Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies by Martin K. H. Ho, Araniy Santhireswaran, Tara Gomes, Muhammad Mamdani, Mina Tadrous

    Published 2025-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: